Key Takeaways
- Medication-assisted treatment with buprenorphine or methadone significantly reduces overdose risk and relapse rates.
- Buprenorphine can be prescribed by waivered providers in office-based settings, widely available in Connecticut.
- Methadone is available through licensed opioid treatment programs (OTPs) in major Connecticut cities.
- Connecticut HUSKY covers both buprenorphine and methadone with minimal prior authorization.
- Combining MAT with behavioral therapy and counseling produces significantly better outcomes.
- Long-term MAT maintenance is appropriate for many individuals; no required timeline for discontinuation exists.
Understanding Medication-Assisted Treatment
Medication-assisted treatment (MAT) is the gold standard for treating opioid use disorders and significantly improves outcomes. MAT combines medication that binds to opioid receptors with behavioral therapy, counseling, and psychosocial support.
Two primary medications are used in MAT: buprenorphine and methadone. Both reduce cravings and prevent withdrawal; both have different potencies, safety profiles, and use patterns.
Medication combined with behavioral support is essential. Medication alone is not adequate; therapy and support are required.
MAT is highly effective and appropriate for long-term use. Call Trust SoCal at (949) 280-8360 to discuss Connecticut MAT options and access.
Buprenorphine: Office-Based MAT
Buprenorphine is a partial opioid agonist with advantages including lower overdose risk and easier tapering. Available as tablets, films, or longer-acting injections. Dosing typically ranges from 4mg to 24mg daily.
Buprenorphine is widely available in Connecticut through office-based providers. Connecticut HUSKY covers buprenorphine with minimal authorization. Excellent for individuals new to MAT or seeking privacy.
Methadone: Opioid Treatment Programs (OTPs)
Methadone is a long-acting synthetic opioid preventing withdrawal for 24+ hours, dispensed from licensed OTPs. Highly effective for severe opioid use disorder.
Methadone requires daily clinic visits initially. Take-home privileges earned through compliance. Appropriate for severe, chronic opioid dependence.
Combining MAT with Behavioral Support
Medication combined with behavioral therapy, counseling, and psychosocial support produces significantly better outcomes. Individual therapy, group therapy, and peer support provide essential components.
Therapy typically continues indefinitely, evolving as individual needs change. For many, therapy provides ongoing support and relapse prevention.
MAT is most effective when combined with regular therapy and support. Engage in counseling and community support for best outcomes.
Long-Term MAT Maintenance
Many individuals benefit from long-term or indefinite MAT maintenance. No universal timeline for discontinuation; duration is individualized based on recovery trajectory and needs.
Medical research supports indefinite MAT for individuals benefiting from it. Medically supervised tapering is available for those deciding to discontinue.
Trust SoCal Editorial Team, Clinical Review Board
Editorial & Clinical Review
